Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Objective: To determine the national prevalence of psychotropic use and association with neuropsychiatric symptoms among patients with dementia. Methods: Participants diagnosed with dementia (n = 414) in the Aging, Demographics, and Memory Study, a nationally representative survey of US adults >70 years old. Diagnosis was based on in‐person clinical assessment and informant interview. Information collected included demographics, place of residence, 10‐item Neuropsychiatric Inventory (NPI), and prescribed medications (antipsychotic, sedative‐hypnotic, antidepressant, mood stabilizer). Results: Of 414 participants with dementia, 41.4% were prescribed a psychotropic medication, including 84.0% of nursing home residents and 28.6% of community‐dwellers. Of participants, 23.5% were prescribed an antidepressant. Compared with the total NPI score of those on no medication (4.5), those on antipsychotics and those on sedative‐hypnotics had much higher scores (respectively: 12.6, p < 0.001; 11.8, p = 0.03), although those antidepressants did not (6.9, p = 0.15). A larger proportion of patients on antipsychotics exhibited psychosis and agitation compared with those on no medication, while those on antidepressants exhibited more depressive symptoms. In multivariable logistic regression that included dementia severity and nursing home residence, nursing home residence was the characteristic most strongly associated with psychotropic use (odds ratio ranging from 8.96 [p < 0.001] for antipsychotics to 15.59 [p < 0.001] for sedative‐hypnotics). More intense psychotic symptoms and agitation were associated with antipsychotic use; more intense anxiety and agitation were associated with sedative‐hypnotic use. More intense depression and apathy were not associated with antidepressant use. Conclusions: In this nationally representative sample, 41.4% of patients were taking psychotropic medication. While associated with neuropsychiatric symptoms, nursing home residence was most strongly tied to use. Copyright © 2016 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, S. (2002) · JAMA · doi:10.1001/jama.288.12.1475 · Cited by 2,049 · cited 2×
“…domains and the average NPI score among the ADAMS participants with dementia were similar to other population-based studies (Lyketsos et al., 2000; Lyketsos et al., 2002) although the NPI total among medication users was relatively low compared with medication trials (Banerjee et al., 2011;…”
ResultPrevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2007) · Neuroepidemiology · doi:10.1159/000109998 · Cited by 1,932 · cited 1×
“Dementia affects a large and growing number of older adults (Plassman et al., 2007).”
BackgroundSelf-citationSchneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671 · cited 2×
“…2015 Beers Criteria Update Expert Panel, 2015), from nausea or hyponatremia with a selective serotonin reuptake inhibitor (SSRI) (Banerjee et al., 2011) to more serious consequences such as falls with benzodiazepines (Wang et al., 2001) and mortality with antipsychotics (Schneider et al., 2005).”
BackgroundAssessment and management of behavioral and psychological symptoms of dementia
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ · doi:10.1136/bmj.h369 · Cited by 1,247 · cited 5×
“Although cognitive impairment is the clinical hallmark of dementia, neuropsychiatric symptoms (NPS) are exceedingly common and often dominate disease presentation (Kales et al., 2015).”
BackgroundInfluentialSelf-citationEffectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
Schneider, L. S., Tariot, P. N., Dagerman, K. S., Davis, S. M., Hsiao, J. K., Ismail, M. S., Lebowitz, B. D., Lyketsos, C. G., Ryan, J. M., Stroup, T. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061240 · Cited by 1,206 · cited 2×
“…NPI score among the ADAMS participants with dementia were similar to other population-based studies (Lyketsos et al., 2000; Lyketsos et al., 2002) although the NPI total among medication users was relatively low compared with medication trials (Banerjee et al., 2011; Schneider et al., 2006).”
ResultLyketsos, C. G., Steinberg, M., Tschanz, J. T., Norton, M. C., Steffens, D. C., & Breitner, J. C. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.708 · Cited by 1,144
Neuropsychiatric symptoms in Alzheimer's disease
Lyketsos, C. G., Carrillo, M. C., Ryan, J. M., Khachaturian, A. S., Trzepacz, P., Amatniek, J., Cedarbaum, J., Brashear, R., & Miller, D. S. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2410 · Cited by 1,139 · cited 1×
“NPS occur in dementia of all types in clusters or syndromes such as depression, psychosis, agitation, and apathy (Lyketsos et al., 2011).”
BackgroundPatient and Caregiver Characteristics and Nursing Home Placement in Patients With Dementia
Yaffe, K. (2002) · JAMA · doi:10.1001/jama.287.16.2090 · Cited by 903 · cited 1×
“Such symptoms, as opposed to core cognitive symptoms, often create the most difficulties for patients, caregivers, and providers and lead to earlier nursing home placement (Yaffe et al., 2002).”
Background
Cited by
Ralph, S. J., & Espinet, A. J. (2018) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-170042 · Cited by 160
“…2000–2011 45,894 Alzheimer’s Dementia patients All-cause Mortality in Dementia patients: Antipsychotics: Atypical and Typical Current antipsychotic users (prior 12 months) HR = 2.31; [2.14–2.49], p < 0.001 Nielsen et al., 2017 [44] Cardiovascular, infection, cancer ATC Code = N05A except Lithium.”
BackgroundInfluentialHazlett-Stevens, H., Singer, J., & Chong, A. (2019) · Clinical Gerontologist · doi:10.1080/07317115.2018.1518282 · Cited by 123
Smeets, C. H. W., Gerritsen, D. L., Zuidema, S. U., Teerenstra, S., van der Spek, K., Smalbrugge, M., & Koopmans, R. T. C. M. (2018) · Aging & Mental Health · doi:10.1080/13607863.2017.1348469 · Cited by 31
Metadata
- Authors
- Maust, D. T., Langa, K. M., Blow, F. C., & Kales, H. C.
- Venue
- International Journal of Geriatric Psychiatry
- Publisher
- Wiley
- Published
- 2016-02-18
- Volume
- 32
- Issue
- 2
- Pages
- 164-174
- ISSN
- 0885-6230 (ISSN-L)
- 1099-1166
- OpenAlex
- W2285128269
- Cited by
- 83
- References
- 18
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.